Reinhard Koenig - Oasmia Pharmaceutical Chief Officer
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Insider
Reinhard Koenig is Chief Officer of Oasmia Pharmaceutical AB
| Age | 63 |
| Phone | 46 18 50 54 40 |
| Web | https://www.vivesto.com |
Oasmia Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of (0.0875) % which means that it has lost $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2542) %, meaning that it generated substantial loss on money invested by shareholders. Oasmia Pharmaceutical's management efficiency ratios could be used to measure how well Oasmia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Paul Cadman | Canada Goose Holdings | 66 | |
| Jacqueline Hernandez | Victorias Secret Co | 54 | |
| Guadalupe Margain | Volaris | 49 | |
| Monica Bernal | Volaris | 42 | |
| Michael Armstrong | Canada Goose Holdings | 48 | |
| Brad Kramer | Victorias Secret Co | N/A | |
| Alain Bellemare | Delta Air Lines | 63 | |
| Michael Blackford | Canada Goose Holdings | 55 | |
| Jose Gutierrez | Volaris | 57 | |
| Kathleen Hogan | Alaska Air Group | 54 | |
| Donna James | Victorias Secret Co | 63 | |
| Christine Rupp | Victorias Secret Co | 55 | |
| Brian Leinbach | Victorias Secret Co | N/A | |
| Isela Cervantes | Volaris | 40 | |
| Adrienne Lofton | Alaska Air Group | 45 | |
| Sarah Davis | Victorias Secret Co | 53 | |
| Diana BirkettRakow | Alaska Air Group | 46 | |
| Peter Donkersloot | Copa Holdings SA | 36 | |
| Dani CM | Canada Goose Holdings | 50 | |
| Anne Sheehan | Victorias Secret Co | 63 | |
| Lauren Peters | Victorias Secret Co | 59 | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 |
Oasmia Pharmaceutical Leadership Team
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson, Chief Officer | ||
| Urban Ekelund, IR Mang | ||
| Henrik Rnnberg, Chief Health | ||
| John Cosby, Head Affairs | ||
| Robert Maiorana, Head CFO | ||
| Dzianis Babrou, Head Devel | ||
| Christer MD, Acting Officer | ||
| Reinhard Koenig, Chief Officer | ||
| Johanna Rostin, Head Affairs | ||
| Maria Hagberg, Head Affairs |
Oasmia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oasmia Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |